Yoann Zadro
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study.
Journal: Haematologica
Published: November 10, 2025
Risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag vs romiplostim: a target trial emulation in the French Adult Immune Thrombocytopenia (FAITH) cohort.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 22, 2025
Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.
Journal: American journal of hematology
Published: September 18, 2025
Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-France.
Journal: American journal of hematology
Published: March 28, 2025
Risk of cancer in adults with primary immune thrombocytopenia: a binational population-based realworld cohort study from Denmark and France.
Journal: Haematologica
Published: January 14, 2025
Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.
Journal: American journal of hematology
Published: October 15, 2024
Use of real-world data for the development and the follow-up of drugs in rare diseases. The example of immune thrombocytopenia and autoimmune hemolytic anemia.
Journal: La Revue de medecine interne
Published: September 01, 2024
Definition of an algorithm to identify patients with sickle-cell disease in the French National Health Database.
Journal: European journal of internal medicine
Published: January 17, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026